Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opexa Therapeutics Inc (NASDAQ:OPXA)

0.3982
Delayed Data
As of Jul 31
 -0.0019 / -0.47%
Today’s Change
0.33
Today|||52-Week Range
1.59
-44.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$21.3M

Company Description

Opexa Therapeutics, Inc. engages as a biopharmaceutical company which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. The company was founded in March 1991 and is headquartered in The Woodlands, TX.

Contact Information

Opexa Therapeutics, Inc.
2635 Technology Forest Boulevard
The Woodlands Texas 77381
P:(281) 775-0600
Investor Relations:

Employees

Shareholders

Other institutional7.78%
Individual stakeholders3.43%
Mutual fund holders2.66%

Top Executives

Neil K. WarmaPresident, Chief Executive Officer & Director
Karthik RadhakrishnanChief Financial Officer
Donald HealeyChief Scientific Officer
Donna R. RillChief Development Officer